Mechanism involved in aged-related endothelial dysfuntion;Mecanismos implicados en la disfunción endotelial asociada al envejecimiento

Medicina Clinica

Volumn 132, Issue 2, 2009, Pages 62-69

  Mingorance, Carmen ^a   Herrera, María Dolores ^a   Álvarez De Sotomayor, María ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Ageing; Endothelium; Nitric oxide; Reactive oxygen species; Senescence

Indexed keywords

NITRIC OXIDE; PROSTANOID; REACTIVE OXYGEN METABOLITE;

AGING; BLOOD VESSEL WALL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; OXIDATIVE STRESS; REVIEW; SENESCENCE;

AGING; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 63149189849     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.09.011     Document Type: Review

References (96)

1. Taddei S., Virdis A., Mattei P., Ghiadoni L., Gennari A., Basile Fasolo C., et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 91 (1995) 1981-1987
2. Badimón L., and Martínez-González J. Endotelio en la protección vascular: nuevos conocimientos. Rev Esp Cardiol. 55 (2002) 17-26
3. Matz R.L., De Sotomayor M.A., Schott C., Stoclet J.C., and Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol. 131 (2000) 303-311
4. Blackwell K.A., Sorenson J.P., Richardson D.M., Smith L.A., Suda O., Nath K., et al. Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol. 287 (2004) H2448-H2453
5. De Sotomayor M.A., Pérez-Guerrero C., Herrrera M.D., Jiménez L., Marín R., Marhuenda E., et al. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol. 146 (2005) 1130-1138
6. Mingorance C., Andriantsitohaina R., and Álvarez de Sotomayor M. Cedrelopsis grevei improves endothelial vasodilatation in aged rats through an increase of NO participation. J Ethnopharmacol. 117 (2008) 76-83
7. Ahlers B.A., Parnell M.M., Chin-Dusting J.P., and Kaye D.M. An age-related decline in endothelial function is not associated with alterations in L-arginine transport in humans. J Hypertens. 22 (2004) 321-327
8. Al-Shaer M.H., Choueiri N.E., Correia M.L., Sinkey C.A., Barenz T.A., and Haynes W.G. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int J Cardiol. 109 (2006) 201-206
9. James M.A., Tullett J., Hemsley A.G., and Shore A.C. Effects of aging and hypertension on the microcirculation. Hypertension. 47 (2006) 968-974
10. Singh N., Prasad S., Singer D.R., and MacAllister R.J. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Clin Sci (Lond). 102 (2002) 595-600
11. Eskurza I., Myerburgh L.A., Kahn Z.D., and Seals D.R. Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J Physiol. 568 (2005) 1057-1065
12. Yavuz B.B., Yavuz B., Sener D.D., Cankurtaran M., Halil M., Ulger Z., et al. Advanced Age Is Associated with Endothelial Dysfunction in Healthy Elderly Subjects. Gerontology. 54 (2008) 153-156
13. Sun D., Huang A., Yan E.H., Wu Z., Yan C., Kaminski P.M., et al. Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol. 286 (2004) H2249-H2256
14. Soucy K.G., Ryoo S., Benjo A., Lim H.K., Gupta G., Sohi J.S., et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol. 101 (2006) 1751-1759
15. Wallace S.M., Yasmin, McEniery C.M., Mäki-Petäjä K.M., Booth A.D., Cockcroft J.R., et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension. 50 (2007) 228-233
16. Burnett A.L. The role of nitric oxide in erectile dysfunction: implications for medical therapy. J Clin Hypertens (Greenwich). 8 Suppl 4 (2006) 53-62
17. Csiszar A., Toth J., Peti-Peterdi J., and Ungvari Z. The aging kidney: role of endothelial oxidative stress and inflammation. Acta Physiol Hung. 94 (2007) 107-115
18. Price J.M., Hellermann A., Hellermann G., and Sutton E.T. Aging enhances vascular dysfunction induced by the Alzheimer's peptide beta-amyloid. Neurol Res. 26 (2004) 305-311
19. Kunieda T., Minamino T., Miura K., Katsuno T., Tateno K., Miyauchi H., et al. Reduced nitric oxide causes age-associated impairment of circadian rhythmicity. Circ Res. 102 (2008) 607-614
20. Sanada M., Taguchi A., Higashi Y., Tsuda M., Kodama I., Yoshizumi M., et al. Forearm endothelial function and bone mineral loss in postmenopausal women. Atherosclerosis. 176 (2004) 387-392
21. Matz R.L., and Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging. 20 (2003) 527-550
22. Berkowitz D.E., White R., Li D., Minhas K.M., Cernetich A., Kim S., et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 108 (2003) 2000-2006
23. White A.R., Ryoo S., Li D., Champion H.C., Steppan J., Wang D., et al. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension. 47 (2006) 245-251
24. Santhanam L., Lim H.K., Miriel V., Brown T., Patel M., Balanson S., et al. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res. 101 (2007) 692-702
25. Cooke J.P. ADMA: its role in vascular disease. Vasc Med. 10 Suppl 1 (2005) S11-S17
26. Gates P.E., Boucher M.L., Silver A.E., Monahan K.D., and Seals D.R. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol. 102 (2007) 63-71
27. Holowatz L.A., Thompson C.S., and Kenney W.L. L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J Physiol. 574 (2006) 573-581
28. Xiong Y., Yuan L.W., Deng H.W., Li Y.J., and Chen B.M. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin Exp Pharmacol Physiol. 28 (2001) 842-847
29. Kielstein J.T., Bode-Böger S.M., Frölich J.C., Ritz E., Haller H., and Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation. 107 (2003) 1891-1895
30. Bode-Böger S.M., Muke J., Surdacki A., Brabant G., Böger R.H., and Frölich J.C. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med. 8 (2003) 77-81
31. Gates P.E., Boucher M.L., Silver A.E., Monahan K.D., and Seals D.R. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol. 102 (2007) 63-71
32. Vásquez-Vivar J., Kalyanaraman B., and Martásek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res. 37 (2003) 121-127
33. Yoshida Y.I., Eda S., and Masada M. Alterations of tetrahydrobiopterin biosynthesis and pteridine levels in mouse tissues during growth and aging. Brain Dev. 22 Suppl 1 (2000) S45-S49
34. Higashi Y., Sasaki S., Nakagawa K., Kimura M., Noma K., Hara K., et al. Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production. Atherosclerosis. 186 (2006) 390-395
35. Cernadas M.R., Sánchez de Miguel L., García-Durán M., González-Fernández F., Millas I., Montón M., et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res. 83 (1998) 279-286
36. Van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 192 (2000) 1731-1744
37. Briones A.M., Montoya N., Giraldo J., and Vila E. Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton Autacoid Pharmacol. 25 (2005) 155-162
38. Goettsch W., Lattmann T., Amann K., Szibor M., Morawietz H., Munter K., et al. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun. 280 (2001) 908-913
39. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 90 (2002) 1159-1166
40. Wu S., Ruan Y., Yin M., and Lai W. Research on the Age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehydroepiandrosterone. Gerontology. 53 (2007) 234-237
41. Smith A.R., Visioli F., and Hagen T.M. Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age. Arch Biochem Biophys. 454 (2006) 100-105
42. Hamilton C.A., Brosnan M.J., McIntyre M., Graham D., and Dominiczak A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 37 (2000) 529-534
43. Csiszar A., Labinskyy N., Orosz Z., and Ungvari Z. Altered mitochondrial energy metabolism may play a role in vascular aging. Med Hypotheses. 67 (2006) 904-908
44. Brown K.A., Chu Y., Lund D.D., Heistad D.D., and Faraci F.M. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am J Physiol Heart Circ Physiol. 290 (2006) H2600-H2605
45. Di Massimo C., Scarpelli P., Di Lorenzo N., Caimi G., Di Orio F., and Ciancarelli M.G. Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci. 78 (2006) 1163-1167
46. Álvarez de Sotomayor M., Mingorance C., and Andriantsitohaina R. Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries. Atherosclerosis. 193 (2007) 112-120
47. Adachi T., Wang J., and Wang X.L. Age-related change of plasma extracellular-superoxide dismutase. Clin Chim Acta. 290 (2000) 169-178
48. Brandes R.P., Fleming I., and Busse R. Endothelial aging. Cardiovasc Res. 6 (2005) 286-294
49. Outdo A., Martin C., Busseuil D., Vergely C., Demaison L., and Rochette L. NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med. 40 (2006) 2214-2222
50. Bruunsgaard H., Skinhøj P., Pedersen A.N., Schroll M., and Pedersen B.K. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol. 121 (2000) 255-260
51. Newaz M.A., Yousefipour Z., and Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. J Cardiovasc Pharmacol. 48 (2006) 88-94
52. Xin M.G., Zhang J., Block E.R., and Patel J.M. Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells. Mech Ageing Dev. 124 (2003) 911-919
53. Madamanchi N.R., and Runge M.S. Mitochondrial dysfunction in atherosclerosis. Circ Res. 100 (2007) 460-473
54. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., Komjáti K., and Szabó C. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol. 135 (2002) 1347-1350
55. Radovits T., Seres L., Gero D., Lin L.N., Beller C.J., Chen S.H., et al. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech Ageing Dev. 128 (2007) 173-181
56. Radovits T., Seres L., Gero D., Berger I., Szabó C., Karck M., et al. Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp Gerontol. 42 (2007) 676-685
57. Heymes C., Habib A., Yang D., Mathieu E., Marotte F., Samuel J., et al. Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol. 131 (2000) 804-810
58. Taddei S., Virdis A., Mattei P., Ghiadoni L., Fasolo C.B., Sudano I., et al. Hypertension causes premature aging of endothelial function in humans. Hypertension. 29 (1997) 736-743
59. Woodman C.R., Price E.M., and Laughlin M.H. Selected Contribution: Aging impairs nitric oxide and prostacyclin mediation of endothelium-dependent dilation in soleus feed arteries. J Appl Physiol. 95 (2003) 2164-2170
60. Spier S.A., Delp M.D., Meininger C.J., Donato A.J., Ramsey M.W., and Muller-Delp J.M. Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles. J Physiol. 56 (2004) 947-958
61. Tang E.H., and Vanhoutte P.M. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics. 32 (2008) 409-418
62. Davidge S.T., Hubel C.A., and McLaughlin M.K. Impairment of vascular function is associated with an age-related increase of lipid peroxidation in rats. Am J Physiol. 271 (1996) R1625-R1631
63. Jaimes J.A., Zhou M.S., Pearse D.D., Puzis L., and Raij L. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol. 294 (2008) F385-F392
64. Mantelli L., Amerini S., and Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol. 25 (1995) 595-602
65. Long D.A., Newaz M.A., Prabhakar S.S., Price K.L., Truong L.D., Feng L., et al. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney Int. 68 (2005) 2154-2163
66. Goto K., Fujii K., Onaka U., Abe I., and Fujishima M. Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction. Hypertension. 36 (2000) 581-587
67. Kansui Y., Fujii K., Goto K., Abe I., and Iida M. Angiotensin II receptor antagonist improves age-related endothelial dysfunction. J Hypertens. 20 (2002) 439-446
68. Álvarez de Sotomayor M, Stoclet JC, Andriantsiohaina R. Effect of ageing on the endothelium-dependent vasorelaxation induced by acetylcholine in rat mesenteric arteries. En: Vanhoutte PM, editor. Endothelium-derived hyperpolarizations. Amsterdam: Harwood Academic Publishers; 1999. p. 323-32.
69. Matz R.L., Schott C., Stoclet J.C., and Andriantsitohaina R. Age-related endothelial dysfunction with respect to NO, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res. 49 (2000) 11-18
70. Büssemaker E., Popp R., Fisslthaler B., Larson C.M., Fleming I., Busse R., et al. Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery. Hypertension. 42 (2003) 562-568
71. Gaubert M.L., Sigaudo-Roussel D., Tartas M., Berrut G., Saumet J.L., and Fromy B. Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice. J Physiol. 585 (2007) 617-626
72. Van Guilder G.P., Westby C.M., Greiner J.J., Stauffer B.L., and DeSouza C.A. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension. 50 (2007) 403-409
73. Donato A.J., Lesniewski L.A., and Delp M.D. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. Cardiovasc Res. 66 (2005) 393-401
74. Korzick D.H., Muller-Delp J.M., Dougherty P., Heaps C.L., Bowles D.K., and Krick K.K. Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C. Cardiovasc Res. 66 (2005) 384-392
75. Maeda S., Miyauchi T., Iemitsu M., Tanabe T., Yokota T., Goto K., et al. Effects of exercise training on expression of endothelin-1 mRNA in the aorta of aged rats. Clin Sci (Lond). 103 Suppl 48 (2002) 118S-123S
76. Bandyopadhyay D, Gatza C, Donehower LA, Medrano EE. Analysis of cellular senescence in culture in vivo: the senescence-associated beta-galactosidase assay. Curr Protoc Cell Biol. 2005;Capítulo 18:Unidad 18.9.
77. Shawi M., and Autexier C. Telomerase, senescence and ageing. Mech Ageing Dev. 129 (2008) 3-10
78. De Meyer T., Rietzschel E.R., De Buyzere M.L., Van Criekinge W., and Bekaert S. Studying telomeres in a longitudinal population based study. Front Biosci. 13 (2008) 2960-2970
79. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., and Tsao P.S. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res. 89 (2001) 793-798
80. Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., and Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol. 23 (2003) 4598-4610
81. Neubert K., Haberland A., Kruse I., Wirth M., and Schimke I. The ratio of formation of prostacyclin/thromboxane A2 in HUVEC decreased in each subsequent passage. Prostaglandins. 54 (1997) 447-462
82. Aviv H., Khan M.Y., Skurnick J., Okuda K., Kimura M., Gardner J., et al. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis. 159 (2001) 281-287
83. Ogami M., Ikura Y., Ohsawa M., Matsuo T., Kayo S., Yoshimi N., et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol. 24 (2004) 546-550
84. Minamino T., and Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 100 (2007) 15-26
85. Ben-Porath I., and Weinberg R.A. When cells get stressed: an integrative view of cellular senescence. J Clin Invest. 113 (2004) 8-13
86. Vasa M., Breitschopf K., Zeiher A.M., and Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res. 87 (2000) 540-542
87. Hayashi T., Matsui-Hirai H., Miyazaki-Akita A., Fukatsu A., Funami J., Ding Q.F., et al. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA. 103 (2006) 17018-17023
88. Breitschopf K., Zeiher A.M., and Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 493 (2001) 21-25
89. Pu D.R., and Liu L. HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med Hypotheses. 70 (2008) 338-342
90. Thum T., Hoeber S., Froese S., Klink I., Stichtenoth D.O., Galuppo P., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res. 100 (2007) 434-443
91. Weinsaft J.W., and Edelberg J.M. Aging-associated changes in vascular activity: a potential link to geriatric cardiovascular disease. Am J Geriatr Cardiol. 10 (2001) 348-354
92. Scheubel R.J., Zorn H., Silber R.E., Kuss O., Morawietz H., Holtz J., et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 42 (2003) 2073-2080
93. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., and Tsao P.S. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res. 89 (2001) 793-798
94. Ballard V.L., and Edelberg J.M. Targets for regulating angiogenesis in the ageing endothelium. Expert Opin Ther Targets. 11 (2007) 1385-1399
95. Facchetti F., Monzani E., Cavallini G., Bergamini E., and La Porta C.A. Effect of a caloric restriction regimen on the angiogenic capacity of aorta and on the expression of endothelin-1 during ageing. Exp Gerontol. 42 (2007) 662-667
96. Singh N., Graves J., Taylor P.D., MacAllister R.J., and Singer D.R. Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res. 56 (2002) 118-125